Word

HANALL BIOPHARMA

Status

Pending

Status Code

681

Status Date

Monday, September 16, 2024

Serial Number

79388966

Mark Type

3

Filing Date

Thursday, November 16, 2023

Published for Opposition

Tuesday, October 22, 2024

Trademark Owner History

Hanall Biopharma Co., Ltd.

Classifications

5 Reagents for use in diagnostic testing of Hepatitis B surface antibody for medical purposes and pharmaceutical agents affecting sensory organs; thyroid and para-thyroid hormone preparations; tonics, namely, medicines for autoimmune disease, ocular disease, ear disease, neurodegenerative disease, and cancer; anthelmintics; antiemetics; local anaesthetics; anti-cough drops; pituitary hormone preparations; pharmaceutical preparations for treating diabetes; pharmaceutical agents affecting metabolism; veterinary preparations for the treatment of autoimmune disease, ocular disease, ear disease, neurodegenerative disease, and cancer; prescription synthetic narcotics; anaesthetics; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations for immunity improvement; pharmaceutical agents for treating physically caused lesions; pharmaceuticals for the treatment of erectile dysfunction; vesicants for wart removal; vaccines; adrenal hormone preparations; pharmaceutical preparations for the treatment of urogenital organs; vitamin preparations; pharmaceutical products for the treatment of bone diseases; crude medicines for the treatment of autoimmune disease, ocular disease, ear disease, neurodegenerative disease, and cancer; anti-inflammatory and antipyretic preparations; pharmaceutical agents affecting digestive organs; biological preparations for veterinary purposes for the treatment of autoimmune disease, ocular disease, ear disease, neurodegenerative disease, and cancer; chemical preparations for veterinary purposes for the treatment of autoimmune disease, ocular disease, ear disease, neurodegenerative disease, and cancer; cardiovascular pharmaceutical preparations; chemico-pharmaceutical preparations for the treatment of autoimmune disease, ocular disease, ear disease, neurodegenerative disease, and cancer; pharmaceutical agents for epidermis; medicines for the treatment of gastrointestinal diseases; diagnostic preparations for medical or veterinary purposes; drugs for medical purposes for the treatment of autoimmune disease, ocular disease, ear disease, neurodegenerative disease, and cancer; medical diagnostic reagents; diuretics; medicines for human purposes for the treatment of autoimmune disease, ocular disease, ear disease, neurodegenerative disease, and cancer; antacids; haematogen; pharmaceutical preparations for the treatment of tumours; pharmaceutical preparations acting on the central nervous system; analgesics; medical preparations for slimming purposes; medicines for dental purposes; dermatological pharmaceutical products; antibiotics; anti-cancer preparations; blood solvents for medical or veterinary purposes; pharmaceutical preparations for the treatment of respiratory organs; preparations for the treatment of burns; chemotherapeutics

35 Price comparison services; distribution of samples; wholesale store services featuring nutraceuticals for use as a dietary supplement; retail store services featuring nutraceuticals for use as a dietary supplement; wholesale store services featuring medical apparatus; retail store services featuring medical apparatus; wholesale store services featuring medical apparatus and instruments; retail store services featuring medical apparatus and instruments; wholesale store services featuring pharmaceuticals; retail store services featuring pharmaceuticals; wholesale store services featuring medicines for human purposes; retail store services featuring medicines for human purposes; wholesale store services featuring fruit-based dietary supplements via the internet; retail store services featuring fruit-based dietary supplements via the internet; wholesale store services featuring make-up preparations via the internet; retail store services featuring make-up preparations via the internet; wholesale store services featuring nutraceuticals via the internet; retail store services featuring nutraceuticals via the internet; wholesale store services featuring make-up preparations; retail store services featuring make-up preparations

42 Advice in the field of construction drafting; engineering surveying; rental of scientific equipment; research relating to mechanical engineering; meteorological observation for others; services for assessing the safety of agricultural chemicals; cosmetology research services; industrial design; pharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical research services; scientific research services in the fields of medicine, health and pharmacology; medical research; product safety testing; textile design; research in the field of computer software development; marine, aerial and land surveying; oceanography research; chemical analysis; scientific research in the nature of providing environmental impact surveys

The mark consists of the stylized wording HANALL BIOPHARMA in black, above the wording are three abstract designs of chromosomes in the colors green, yellow, and blue.
The color(s) black, green, yellow and blue is/are claimed as a feature of the mark.
BIOPHARMA

Trademark Events

Jun 24, 2024

Non-Final Action Written

Jun 25, 2024

Non-Final Action (Ib Refusal) Prepared For Review

Jul 16, 2024

Non-Final Action Mailed - Refusal Sent To Ib

Jul 16, 2024

Refusal Processed By Mpu

Feb 9, 2024

Sn Assigned For Sect 66a Appl From Ib

Feb 12, 2024

New Application Office Supplied Data Entered

Feb 16, 2024

Application Filing Receipt Mailed

Jun 21, 2024

Assigned To Examiner

Sep 6, 2024

Teas/Email Correspondence Entered

Sep 6, 2024

Correspondence Received In Law Office

Sep 6, 2024

Teas Response To Office Action Received

Sep 12, 2024

Approved For Pub - Principal Register

Oct 2, 2024

Notification Of Notice Of Publication E-Mailed

Aug 4, 2024

Refusal Processed By Ib